Literature DB >> 15370019

Impact of the heroin 'drought' on patterns of drug use and drug-related harms.

Marie C Longo1, Susan M Henry-Edwards, Rachel E Humeniuk, Paul Christie, Robert L Ali.   

Abstract

Since late 2000, anecdotal reports from drug users and health professionals have suggested that there was a reduction in the supply of heroin in Adelaide in the first half of 2001, referred to as a heroin 'drought'. The aim of this paper was to critically review evidence for this, using data obtained from 100 injecting drug users surveyed for the 2001 Illicit Drug Reporting System (IDRS). This project is carried out annually in all Australian jurisdictions, and collects up-to-date information on the markets for heroin, methamphetamine, cocaine and cannabis. This paper also investigates the possible implications of this 'drought' on patterns of drug use and drug-related harms. The 2001 IDRS found consistent reports by users of an increase in the price of heroin, together with decreases in purity and availability. These factors resulted in a decrease in the frequency of self-reported heroin use among those surveyed in 2001, and a concomitant increase in the use of other drugs, in particular methamphetamine and morphine. The heroin 'drought' appears to have had a substantial impact on several indices of drug-related harm. There was a marked decrease in the number of opioid-related fatalities, and hospital data also showed reductions in heroin-related presentations. Treatment service data showed an increase in the number of admissions related to amphetamines. There is a need for health promotion and education on the adverse effects of methamphetamine use, and the development of improved treatment protocols for methamphetamine abuse and dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370019     DOI: 10.1080/09595230410001704118

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  8 in total

1.  Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform.

Authors:  Dan Werb; Steffanie A Strathdee; Emilo Meza; Maria Gudelia Rangel Gomez; Lawrence Palinkas; Maria Elena Medina-Mora; Leo Beletsky
Journal:  Glob Public Health       Date:  2015-12-13

2.  Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.

Authors:  Gary K Hulse; Robert J Tait; Sandra D Comer; Maria A Sullivan; Ian G Jacobs; Diane Arnold-Reed
Journal:  Drug Alcohol Depend       Date:  2005-09-01       Impact factor: 4.492

Review 3.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

4.  Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.

Authors:  Ricky N Bluthenthal; Kelsey Simpson; Rachel Carmen Ceasar; Johnathan Zhao; Lynn Wenger; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2020-03-18       Impact factor: 4.492

5.  The "lessons" of the Australian "heroin shortage".

Authors:  Louisa Degenhardt; Carolyn Day; Stuart Gilmour; Wayne Hall
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-05-02

Review 6.  A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.

Authors:  David R Gastfriend
Journal:  Ann N Y Acad Sci       Date:  2014-09-18       Impact factor: 5.691

7.  The temporal relationship between drug supply indicators: an audit of international government surveillance systems.

Authors:  Dan Werb; Thomas Kerr; Bohdan Nosyk; Steffanie Strathdee; Julio Montaner; Evan Wood
Journal:  BMJ Open       Date:  2013-09-30       Impact factor: 2.692

8.  Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.

Authors:  Andrew McAuley; Janet Bouttell; Lee Barnsdale; Daniel Mackay; Jim Lewsey; Carole Hunter; Mark Robinson
Journal:  Addiction       Date:  2016-11-06       Impact factor: 6.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.